What if AI’s best regulatory use isn’t writing your submission, but finding the weaknesses before FDA does?
In this clip from The Outsourcing Advisor, Bikash Chatterjee explains why AI may be most valuable as a stress test, not just a writing tool. shorturl.at/nbpSo
#AI #FDA #Biopharma #Outsourcing
